U.S. Pharmaceutical sales increased 16.6 % and international pharmaceutical product sales increased 21.3 %, driven by double-digit growth in HUMIRA, Kaletra and TriCor, and including $179 million of Niaspan sales. HUMIRA accomplished full-year worldwide sales more than $3 billion in 2007 and the business forecasts global sales for HUMIRA of approximately $4 billion in 2008. Worldwide medical products sales increased 11.5 %, powered by 15.2 % growth in worldwide Diabetes Treatment product sales and 16.4 % growth in international diagnostics sales. Worldwide nutritional products product sales were led by 26.2 % development in international nutritionals, with continued solid functionality in key emerging growth markets. The strength and balance of Abbott’s broad mix of businesses helped us to deliver another year of constant performance, said Kilometers D.Adrenocorticotropic hormone may help treat people with multiple sclerosis A new study shows that treatment with adrenocorticotropic hormone could be ideal for people whose multiple sclerosis isn’t well-controlled through their regular treatment. The study was released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in NORTH PARK, March 16 to 23, 2013. The study involved 23 people with MS who were acquiring beta-interferon treatment and got at least one relapse or mind scan showing fresh disease activity within the previous year.